Seeing Is Believing
Currently out of the existing stock ratings of Tiago Fauth, 137 are a BUY (73.66%), 44 are a HOLD (23.66%), 5 are a SELL (2.69%).
Analyst Tiago Fauth, currently employed at WELLS FARGO, carries an average stock price target met ratio of 42.65% that have a potential upside of 24.12% achieved within 121 days. Previously, Tiago Fauth worked at CREDIT SUISSE.
Tiago Fauth’s has documented 371 price targets and ratings displayed on 39 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on WVE, Wave Life Sciences Ltd at 03-Sep-2025.
Analyst best performing recommendations are on HGEN (HUMANIGEN).
The best stock recommendation documented was for HGEN (HUMANIGEN) at 7/13/2022. The price target of $0.5 was fulfilled within 2 days with a profit of $0.11 (18.03%) receiving and performance score of 90.16.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$10
$4.47 (80.83%)
$5
2 months 29 days ago
(14-Jul-2025)
4/7 (57.14%)
$5.76 (135.85%)
331
Buy
$10
$4.47 (80.83%)
$29
4 months 27 days ago
(16-May-2025)
0/2 (0%)
$7.97 (392.61%)
Hold
7 months 10 days ago
(02-Mar-2025)
0/2 (0%)
$6.55 (120.18%)
Buy
$5
$-0.53 (-9.58%)
$22
11 months 8 days ago
(04-Nov-2024)
1/4 (25%)
$2.28 (83.82%)
258
Buy
$24
$18.47 (334.00%)
$30
2 years 2 months 9 days ago
(04-Aug-2023)
0/2 (0%)
$17.96 (297.35%)
Which stock is Tiago Fauth is most bullish on?
Which stock is Tiago Fauth is most reserved on?
What Year was the first public recommendation made by Tiago Fauth?